Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gen-Probe outside Roche, Chugai merger

This article was originally published in Clinica

Executive Summary

Chugai Pharmaceutical's US diagnostics and blood screening unit, Gen-Probe, is to be spun off following the Tokyo company's acquisition by Switzerland's Roche Holding. The purchase of a majority holding in Chugai, announced last week, is expected to be completed by the last quarter of 2002 year, says Roche, whereafter Nippon Roche and Chugai will merge. The spin-off of San Diego-based Gen-Probe will take place prior to completion of the merger. Chugai will keep its name, but be known as a "member company of Roche".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel